How the Brain Increases Blood Flow on Demand

New findings could improve understanding of neurodegeneration, interpretation of brain scans

A network of thin red lines on skull-shaped gray background
Blood vessels in the brain. Image: mr.suphachai praserdumrongchai/iStock/Getty Images Plus

At a glance:

  • A new study in mice describes how the brain rapidly and efficiently increases blood flow to active areas where oxygen and nutrients are needed most.

  • The work shows that the brain relies on a communication highway of tightly interlaced cells lining its blood vessels.

  • The insights could advance understanding of neurodegenerative diseases and improve interpretation of brain imaging.

Work described in this story was made possible in part by federal funding supported by taxpayers. At Harvard Medical School, the future of efforts like this — done in service to humanity — now hangs in the balance due to the government’s decision to terminate large numbers of federally funded grants and contracts across Harvard University.

All day long, our brains carry out complicated and energy-intensive tasks such as remembering, solving problems, and making decisions.

To supply the energy these tasks require while conserving this precious fuel, the brain has evolved a system that allows it to quickly and efficiently send blood only to the areas that need it most in any given moment. This system is essential to brain function and overall health, yet how it works has remained somewhat of a mystery.

Get more HMS news

Now, a team led by researchers at Harvard Medical School has uncovered new details of how the brain moves blood to active areas in real time. Their findings are published July 16 in Cell.

In experiments in mice, the team discovered that the brain uses specialized channels in the lining of its blood vessels to communicate where blood is needed.

“This work helps us understand how you can get that super-important blood supply to the correct areas of the brain on a time scale that is useful,” said co-lead author Luke Kaplan, a research fellow in neurobiology in the Blavatnik Institute at HMS.

If confirmed in additional studies in animals and humans, the findings could be used to better understand findings on brain imaging tests such as functional MRI (fMRI). The insights may also advance understanding of neurodegenerative diseases, in which this communication system often breaks down, leading to cognitive problems.

A long-standing mechanistic puzzle

In the late 1800s, Italian physician Angelo Mosso observed something intriguing in a patient with a skull defect that left an area of his brain exposed: When the patient got angry, parts of the exposed area instantly swelled with blood — hinting at a connection between brain activity and blood flow.

A century later, this connection became the basis of fMRI, a type of brain scan that measures blood flow to different regions as a proxy for neural activity while individuals perform various tasks.

The brain is one of the body’s most energy-demanding organs, accounting for 2 percent of the body’s weight but consuming 20 percent of its total energy. To stay within budget, the brain must be highly efficient: It rapidly directs blood flow to the regions that need it the most, explained senior author Chenghua Gu, professor of neurobiology at HMS.

Authorship, funding, disclosures

Additional authors on the paper include Kathleen Navas, Lujing Chen, Austin Birmingham, Daniel Ryvkin, Victoria Izsa, Megan Powell, Zhuhao Wu, and Benjamin Deverman.

The study was funded by a National Science Foundation Graduate Research Fellowship, an HMS Mahoney Postdoctoral Fellowship, an HMS Lefler Postdoctoral Fellowship, the National Institutes of Health (RF1MH128969; HL153261; R35NS116820), the National Institute of Neurological Disorders and Stroke (UG3NS111689), the National Institute of Mental Health (UG3MH120096), the Stanley Center for Psychiatric Research, and a Fidelity Biosciences Research Initiative. Gu is an investigator of the Howard Hughes Medical Institute.

Deverman is listed as an inventor on a patent application (US20240325568A1) for production and use of the AAV-BI30 vector. Deverman is a scientific founder and scientific advisor of Apertura Gene Therapy, received research funding from Apertura Gene Therapy, and is on the scientific advisory board of Tevard Biosciences.